{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T03:20:46Z","timestamp":1791861646258,"version":"4.3.4"},"reference-count":178,"publisher":"Springer Science and Business Media LLC","issue":"S1","license":[{"start":{"date-parts":[[2024,12,30]],"date-time":"2024-12-30T00:00:00Z","timestamp":1735516800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"},{"start":{"date-parts":[[2024,12,30]],"date-time":"2024-12-30T00:00:00Z","timestamp":1735516800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Infect Dis Ther"],"published-print":{"date-parts":[[2025,1]]},"DOI":"10.1007\/s40121-024-01080-4","type":"journal-article","created":{"date-parts":[[2024,12,30]],"date-time":"2024-12-30T11:02:16Z","timestamp":1735556536000},"page":"5-37","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":85,"title":["Burden of Acute Respiratory Infections Caused by Influenza Virus, Respiratory Syncytial Virus, and SARS-CoV-2 with Consideration of Older Adults: A Narrative Review"],"prefix":"10.1007","volume":"14","author":[{"given":"William P.","family":"Hanage","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"William","family":"Schaffner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,12,30]]},"reference":[{"key":"1080_CR1","doi-asserted-by":"publisher","first-page":"175346662199505","DOI":"10.1177\/1753466621995050","volume":"15","author":"A Watson","year":"2021","unstructured":"Watson A, Wilkinson TMA. Respiratory viral infections in the elderly. Ther Adv Respir Dis. 2021;15:1753466621995050. https:\/\/doi.org\/10.1177\/1753466621995050.","journal-title":"Ther Adv Respir Dis"},{"key":"1080_CR2","unstructured":"United Nations. World Social Report 2023: Leaving no one behind in an ageing world. https:\/\/desapublications.un.org\/publications\/world-social-report-2023-leaving-no-one-behind-ageing-world. Accessed 20 Feb 2024."},{"key":"1080_CR3","unstructured":"World Health Organization. Influenza (seasonal) https:\/\/www.who.int\/news-room\/fact-sheets\/detail\/influenza-(seasonal). Accessed 20 Feb 2024."},{"issue":"10127","key":"1080_CR4","doi-asserted-by":"publisher","first-page":"1285","DOI":"10.1016\/s0140-6736(17)33293-2","volume":"391","author":"AD Iuliano","year":"2018","unstructured":"Iuliano AD, Roguski KM, Chang HH, et al. Estimates of global seasonal influenza-associated respiratory mortality: a modelling study. Lancet. 2018;391(10127):1285\u2013300. https:\/\/doi.org\/10.1016\/s0140-6736(17)33293-2.","journal-title":"Lancet"},{"key":"1080_CR5","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.f5061","volume":"347","author":"D Mertz","year":"2013","unstructured":"Mertz D, Kim TH, Johnstone J, et al. Populations at risk for severe or complicated influenza illness: systematic review and meta-analysis. BMJ. 2013;347: f5061. https:\/\/doi.org\/10.1136\/bmj.f5061.","journal-title":"BMJ"},{"key":"1080_CR6","unstructured":"Centers for Disease Control and Prevention. Influenza (Flu) Flu Season. https:\/\/www.cdc.gov\/flu\/about\/season\/index.html#:~:text=In%20the%20United%20States%2C%20flu%20season%20usually%20occurs%20in%20the,peaks%20between%20December%20and%20February. Accessed 20 Feb 2024."},{"key":"1080_CR7","unstructured":"World Health Organization. Influenza Laboratory surveillance Information Virus Detections by Subtype Reported to FluNet. https:\/\/app.powerbi.com\/view?r=eyJrIjoiZTkyODcyOTEtZjA5YS00ZmI0LWFkZGUtODIxNGI5OTE3YjM0IiwidCI6ImY2MTBjMGI3LWJkMjQtNGIzOS04MTBiLTNkYzI4MGFmYjU5MCIsImMiOjh9. Accessed 20 Feb 2024."},{"key":"1080_CR8","unstructured":"Centers for Disease Control and Prevention. Types of Influenza Viruses. https:\/\/www.cdc.gov\/flu\/about\/viruses\/types.htm. Accessed 20 Feb 2024."},{"key":"1080_CR9","unstructured":"World Health Organization. Vaccines Against Influenza: WHO Position Paper\u2014May 2022. https:\/\/www.who.int\/publications\/i\/item\/who-wer9719. Accessed 20 Feb 2024."},{"issue":"1","key":"1080_CR10","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1038\/s41572-018-0002-y","volume":"4","author":"F Krammer","year":"2018","unstructured":"Krammer F, Smith GJD, Fouchier RAM, et al. Influenza. Nat Rev Dis Primers. 2018;4(1):3. https:\/\/doi.org\/10.1038\/s41572-018-0002-y.","journal-title":"Nat Rev Dis Primers"},{"issue":"2","key":"1080_CR11","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2022.0527","volume":"5","author":"CL Hansen","year":"2022","unstructured":"Hansen CL, Chaves SS, Demont C, Viboud C. Mortality associated with influenza and respiratory syncytial virus in the US, 1999\u20132018. JAMA Netw Open. 2022;5(2): e220527. https:\/\/doi.org\/10.1001\/jamanetworkopen.2022.0527.","journal-title":"JAMA Netw Open"},{"issue":"1","key":"1080_CR12","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1186\/s12889-017-4177-z","volume":"17","author":"G Matias","year":"2017","unstructured":"Matias G, Taylor R, Haguinet F, Schuck-Paim C, Lustig R, Shinde V. Estimates of hospitalization attributable to influenza and RSV in the US during 1997\u20132009, by age and risk status. BMC Public Health. 2017;17(1):271. https:\/\/doi.org\/10.1186\/s12889-017-4177-z.","journal-title":"BMC Public Health"},{"key":"1080_CR13","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1186\/s12979-020-00181-1","volume":"17","author":"JE McElhaney","year":"2020","unstructured":"McElhaney JE, Verschoor CP, Andrew MK, Haynes L, Kuchel GA, Pawelec G. The immune response to influenza in older humans: beyond immune senescence. Immun Ageing. 2020;17:10. https:\/\/doi.org\/10.1186\/s12979-020-00181-1.","journal-title":"Immun Ageing"},{"issue":"2","key":"1080_CR14","doi-asserted-by":"publisher","DOI":"10.7189\/jogh.09.020421","volume":"9","author":"J Paget","year":"2019","unstructured":"Paget J, Spreeuwenberg P, Charu V, et al. Global mortality associated with seasonal influenza epidemics: new burden estimates and predictors from the GLaMOR Project. J Glob Health. 2019;9(2): 020421. https:\/\/doi.org\/10.7189\/jogh.09.020421.","journal-title":"J Glob Health"},{"issue":"11","key":"1080_CR15","doi-asserted-by":"publisher","first-page":"e903","DOI":"10.1016\/s2666-5247(23)00187-8","volume":"4","author":"KM Sumner","year":"2023","unstructured":"Sumner KM, Masalovich S, O\u2019Halloran A, et al. Severity of influenza-associated hospitalisations by influenza virus type and subtype in the USA, 2010\u201319: a repeated cross-sectional study. Lancet Microbe. 2023;4(11):e903\u201312. https:\/\/doi.org\/10.1016\/s2666-5247(23)00187-8.","journal-title":"Lancet Microbe"},{"issue":"1","key":"1080_CR16","doi-asserted-by":"publisher","first-page":"2336357","DOI":"10.1080\/21645515.2024.2336357","volume":"20","author":"CA Russell","year":"2024","unstructured":"Russell CA, Fouchier RAM, Ghaswalla P, et al. Seasonal influenza vaccine performance and the potential benefits of mRNA vaccines. Hum Vaccin Immunother. 2024;20(1):2336357. https:\/\/doi.org\/10.1080\/21645515.2024.2336357.","journal-title":"Hum Vaccin Immunother"},{"key":"1080_CR17","unstructured":"Centers for Disease Control and Prevention. How Flu Viruses Can Change: \u201cDrift\u201d and \u201cShift\u201d. https:\/\/www.cdc.gov\/flu\/about\/viruses\/change.htm. Accessed 20 Feb 2024."},{"issue":"4","key":"1080_CR18","doi-asserted-by":"publisher","first-page":"1601","DOI":"10.1007\/s12325-023-02432-1","volume":"40","author":"J Langer","year":"2023","unstructured":"Langer J, Welch VL, Moran MM, et al. High clinical burden of influenza disease in adults aged \u2265 65 years: can we do better? A systematic literature review. Adv Ther. 2023;40(4):1601\u201327. https:\/\/doi.org\/10.1007\/s12325-023-02432-1.","journal-title":"Adv Ther"},{"issue":"1","key":"1080_CR19","doi-asserted-by":"publisher","DOI":"10.1111\/irv.13031","volume":"17","author":"M Savic","year":"2023","unstructured":"Savic M, Penders Y, Shi T, Branche A, Pir\u00e7on JY. Respiratory syncytial virus disease burden in adults aged 60 years and older in high-income countries: a systematic literature review and meta-analysis. Influenza Other Respir Viruses. 2023;17(1): e13031. https:\/\/doi.org\/10.1111\/irv.13031.","journal-title":"Influenza Other Respir Viruses"},{"issue":"6","key":"1080_CR20","doi-asserted-by":"publisher","first-page":"1004","DOI":"10.1093\/cid\/ciab595","volume":"74","author":"AR Branche","year":"2022","unstructured":"Branche AR, Saiman L, Walsh EE, et al. Incidence of respiratory syncytial virus infection among hospitalized adults, 2017\u20132020. Clin Infect Dis. 2022;74(6):1004\u201311. https:\/\/doi.org\/10.1093\/cid\/ciab595.","journal-title":"Clin Infect Dis"},{"issue":"4","key":"1080_CR21","doi-asserted-by":"publisher","first-page":"1137","DOI":"10.1007\/s40121-023-00792-3","volume":"12","author":"Y Li","year":"2023","unstructured":"Li Y, Kulkarni D, Begier E, et al. Adjusting for case under-ascertainment in estimating RSV hospitalisation burden of older adults in high-income countries: a systematic review and modelling study. Infect Dis Ther. 2023;12(4):1137\u201349. https:\/\/doi.org\/10.1007\/s40121-023-00792-3.","journal-title":"Infect Dis Ther"},{"issue":"7","key":"1080_CR22","doi-asserted-by":"publisher","first-page":"ofac300","DOI":"10.1093\/ofid\/ofac300","volume":"9","author":"JM McLaughlin","year":"2022","unstructured":"McLaughlin JM, Khan F, Begier E, Swerdlow DL, Jodar L, Falsey AR. Rates of medically attended RSV among US adults: a systematic review and meta-analysis. Open Forum Infect Dis. 2022;9(7):ofac300. https:\/\/doi.org\/10.1093\/ofid\/ofac300.","journal-title":"Open Forum Infect Dis"},{"issue":"7980","key":"1080_CR23","doi-asserted-by":"publisher","first-page":"S58","DOI":"10.1038\/d41586-023-02958-y","volume":"621","author":"R Nuwer","year":"2023","unstructured":"Nuwer R. Better awareness of RSV in older adults is needed to fight a growing burden. Nature. 2023;621(7980):S58\u20139. https:\/\/doi.org\/10.1038\/d41586-023-02958-y.","journal-title":"Nature"},{"issue":"10340","key":"1080_CR24","doi-asserted-by":"publisher","first-page":"2047","DOI":"10.1016\/s0140-6736(22)00478-0","volume":"399","author":"Y Li","year":"2022","unstructured":"Li Y, Wang X, Blau DM, et al. Global, regional, and national disease burden estimates of acute lower respiratory infections due to respiratory syncytial virus in children younger than 5 years in 2019: a systematic analysis. Lancet. 2022;399(10340):2047\u201364. https:\/\/doi.org\/10.1016\/s0140-6736(22)00478-0.","journal-title":"Lancet"},{"issue":"2","key":"1080_CR25","doi-asserted-by":"publisher","first-page":"677","DOI":"10.1007\/s40121-023-00758-5","volume":"12","author":"MH Rozenbaum","year":"2023","unstructured":"Rozenbaum MH, Judy J, Tran D, Yacisin K, Kurosky SK, Begier E. Low levels of RSV testing among adults hospitalized for lower respiratory tract infection in the United States. Infect Dis Ther. 2023;12(2):677\u201385. https:\/\/doi.org\/10.1007\/s40121-023-00758-5.","journal-title":"Infect Dis Ther"},{"key":"1080_CR26","unstructured":"National Foundation for Infectious Diseases. Progress Report: Reducing the Burden of RSV across the Lifespan. https:\/\/www.nfid.org\/resource\/progress-report-reducing-the-burden-of-rsv-across-the-lifespan\/. Accessed 20 Feb 2024."},{"issue":"4","key":"1080_CR27","doi-asserted-by":"publisher","first-page":"565","DOI":"10.1016\/j.vaccine.2018.12.031","volume":"37","author":"LP Hurley","year":"2019","unstructured":"Hurley LP, Allison MA, Kim L, et al. Primary care physicians\u2019 perspectives on respiratory syncytial virus (RSV) disease in adults and a potential RSV vaccine for adults. Vaccine. 2019;37(4):565\u201370. https:\/\/doi.org\/10.1016\/j.vaccine.2018.12.031.","journal-title":"Vaccine"},{"issue":"9","key":"1080_CR28","doi-asserted-by":"publisher","first-page":"1356","DOI":"10.1093\/infdis\/jiy056","volume":"217","author":"P Obando-Pacheco","year":"2018","unstructured":"Obando-Pacheco P, Justicia-Grande AJ, Rivero-Calle I, et al. Respiratory syncytial virus seasonality: a global overview. J Infect Dis. 2018;217(9):1356\u201364. https:\/\/doi.org\/10.1093\/infdis\/jiy056.","journal-title":"J Infect Dis"},{"issue":"1","key":"1080_CR29","doi-asserted-by":"publisher","first-page":"234","DOI":"10.1080\/21645515.2017.1403707","volume":"14","author":"S Janet","year":"2018","unstructured":"Janet S, Broad J, Snape MD. Respiratory syncytial virus seasonality and its implications on prevention strategies. Hum Vaccin Immunother. 2018;14(1):234\u201344. https:\/\/doi.org\/10.1080\/21645515.2017.1403707.","journal-title":"Hum Vaccin Immunother"},{"key":"1080_CR30","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1186\/1743-422x-11-36","volume":"11","author":"F de Paris","year":"2014","unstructured":"de Paris F, Beck C, de Souza NL, et al. Evaluation of respiratory syncytial virus group A and B genotypes among nosocomial and community-acquired pediatric infections in Southern Brazil. Virol J. 2014;11:36. https:\/\/doi.org\/10.1186\/1743-422x-11-36.","journal-title":"Virol J."},{"issue":"2","key":"1080_CR31","doi-asserted-by":"publisher","first-page":"67","DOI":"10.3390\/pathogens8020067","volume":"8","author":"MC Pandya","year":"2019","unstructured":"Pandya MC, Callahan SM, Savchenko KG, Stobart CC. A contemporary view of respiratory syncytial virus (RSV) biology and strain-specific differences. Pathogens. 2019;8(2):67. https:\/\/doi.org\/10.3390\/pathogens8020067.","journal-title":"Pathogens"},{"issue":"1","key":"1080_CR32","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1128\/cmr.13.1.1","volume":"13","author":"WM Sullender","year":"2000","unstructured":"Sullender WM. Respiratory syncytial virus genetic and antigenic diversity. Clin Microbiol Rev. 2000;13(1):1\u201315. https:\/\/doi.org\/10.1128\/cmr.13.1.1. (Table of contents).","journal-title":"Clin Microbiol Rev"},{"key":"1080_CR33","unstructured":"Cascella M, Rajnik M, Aleem A, Dulebohn SC, Di Napoli R. Features, Evaluation, and Treatment of Coronavirus (COVID-19). StatPearls. Treasure Island (FL): StatPearls Publishing Copyright \u00a9 2024, StatPearls Publishing LLC.; 2024."},{"key":"1080_CR34","unstructured":"World Health Organization. WHO COVID-19 Dashboard: Cases. https:\/\/data.who.int\/dashboards\/covid19\/cases. Accessed 20 Feb 2024."},{"key":"1080_CR35","unstructured":"World Health Organization. WHO COVID-19 Dashboard: Deaths. https:\/\/data.who.int\/dashboards\/covid19\/deaths. Accessed 20 Feb 2024."},{"key":"1080_CR36","unstructured":"Centers for Disease Control and Prevention. Underlying Medical Conditions Associated with Higher Risk for Severe COVID-19: Information for Healthcare Professionals. https:\/\/www.cdc.gov\/covid\/hcp\/clinical-care\/underlying-conditions.html. Accessed 20 Feb 2024."},{"key":"1080_CR37","doi-asserted-by":"publisher","unstructured":"Ahmad FB, Cisewski JA, Xu J, Anderson RN. COVID-19 Mortality Update\u2014United States, 2022. MMWR Morb Mortal Wkly Rep. 2023;72(18):493\u20136. https:\/\/doi.org\/10.15585\/mmwr.mm7218a4.","DOI":"10.15585\/mmwr.mm7218a4"},{"key":"1080_CR38","doi-asserted-by":"publisher","unstructured":"Taylor CA, Patel K, Patton ME, et al. COVID-19-associated hospitalizations among U.S. adults aged \u226565 years\u2014COVID-NET, 13 states, January\u2013August 2023. MMWR Morb Mortal Wkly Rep. 2023;72(40):1089\u201394. https:\/\/doi.org\/10.15585\/mmwr.mm7240a3.","DOI":"10.15585\/mmwr.mm7240a3"},{"key":"1080_CR39","doi-asserted-by":"publisher","unstructured":"Wong MK, Brooks DJ, Ikejezie J, et al. COVID-19 mortality and progress toward vaccinating older adults\u2014World Health Organization, worldwide, 2020\u20132022. MMWR Morb Mortal Wkly Rep. 2023;72(5):113\u20138. https:\/\/doi.org\/10.15585\/mmwr.mm7205a1.","DOI":"10.15585\/mmwr.mm7205a1"},{"key":"1080_CR40","first-page":"1","volume":"446","author":"B Tejada-Vera","year":"2022","unstructured":"Tejada-Vera B, Kramarow EA. COVID-19 mortality in adults aged 65 and over: United States, 2020. NCHS Data Brief. 2022;446:1\u20138.","journal-title":"NCHS Data Brief"},{"issue":"9","key":"1080_CR41","doi-asserted-by":"publisher","first-page":"1856","DOI":"10.3201\/eid2809.220613","volume":"28","author":"YM Mefsin","year":"2022","unstructured":"Mefsin YM, Chen D, Bond HS, et al. Epidemiology of infections with SARS-CoV-2 omicron BA.2 variant, Hong Kong, January-March 2022. Emerg Infect Dis. 2022;28(9):1856\u20138. https:\/\/doi.org\/10.3201\/eid2809.220613.","journal-title":"Emerg Infect Dis"},{"issue":"3","key":"1080_CR42","doi-asserted-by":"publisher","first-page":"162","DOI":"10.1038\/s41579-022-00841-7","volume":"21","author":"AM Carabelli","year":"2023","unstructured":"Carabelli AM, Peacock TP, Thorne LG, et al. SARS-CoV-2 variant biology: immune escape, transmission and fitness. Nat Rev Microbiol. 2023;21(3):162\u201377. https:\/\/doi.org\/10.1038\/s41579-022-00841-7.","journal-title":"Nat Rev Microbiol"},{"issue":"27","key":"1080_CR43","doi-asserted-by":"publisher","first-page":"E1059","DOI":"10.1503\/cmaj.1095949","volume":"193","author":"D Duong","year":"2021","unstructured":"Duong D. Alpha, Beta, Delta, Gamma: what\u2019s important to know about SARS-CoV-2 variants of concern? CMAJ. 2021;193(27):E1059\u201360. https:\/\/doi.org\/10.1503\/cmaj.1095949.","journal-title":"CMAJ"},{"issue":"9","key":"1080_CR44","doi-asserted-by":"publisher","first-page":"1231","DOI":"10.1093\/infdis\/jiad236","volume":"228","author":"JY Wong","year":"2023","unstructured":"Wong JY, Cheung JK, Lin Y, et al. Intrinsic and effective severity of coronavirus disease 2019 cases infected with the ancestral strain and omicron BA.2 variant in Hong Kong. J Infect Dis. 2023;228(9):1231\u20139. https:\/\/doi.org\/10.1093\/infdis\/jiad236.","journal-title":"J Infect Dis"},{"issue":"5","key":"1080_CR45","doi-asserted-by":"publisher","first-page":"e364","DOI":"10.1016\/s2468-2667(23)00079-8","volume":"8","author":"L Nab","year":"2023","unstructured":"Nab L, Parker EPK, Andrews CD, et al. Changes in COVID-19-related mortality across key demographic and clinical subgroups in England from 2020 to 2022: a retrospective cohort study using the OpenSAFELY platform. Lancet Public Health. 2023;8(5):e364\u201377. https:\/\/doi.org\/10.1016\/s2468-2667(23)00079-8.","journal-title":"Lancet Public Health"},{"issue":"5","key":"1080_CR46","doi-asserted-by":"publisher","first-page":"e327","DOI":"10.1016\/s2468-2667(23)00078-6","volume":"8","author":"MW Tenforde","year":"2023","unstructured":"Tenforde MW, Link-Gelles R. Reduction in COVID-19-related mortality over time but disparities across population subgroups. Lancet Public Health. 2023;8(5):e327\u20138. https:\/\/doi.org\/10.1016\/s2468-2667(23)00078-6.","journal-title":"Lancet Public Health"},{"key":"1080_CR47","unstructured":"Centers for Disease Control and Prevention. COVID-NET Interactive Dashboard. https:\/\/www.cdc.gov\/coronavirus\/2019-ncov\/covidnetdashboard\/de\/powerbi\/dashboard.html. Accessed 20 Feb 2024."},{"issue":"8","key":"1080_CR48","doi-asserted-by":"publisher","first-page":"e409","DOI":"10.1016\/s2666-7568(23)00099-5","volume":"4","author":"S Carazo","year":"2023","unstructured":"Carazo S, Skowronski DM, Brisson M, et al. Effectiveness of previous infection-induced and vaccine-induced protection against hospitalisation due to omicron BA subvariants in older adults: a test-negative, case-control study in Quebec, Canada. Lancet Healthy Longev. 2023;4(8):e409\u201320. https:\/\/doi.org\/10.1016\/s2666-7568(23)00099-5.","journal-title":"Lancet Healthy Longev"},{"key":"1080_CR49","doi-asserted-by":"publisher","unstructured":"Voss WN, Mallory MA, Byrne PO, et al. Hybrid immunity to SARS-CoV-2 arises from serological recall of IgG antibodies distinctly imprinted by infection or vaccination. bioRxiv. 2024. https:\/\/doi.org\/10.1101\/2024.01.22.576742.","DOI":"10.1101\/2024.01.22.576742"},{"issue":"1","key":"1080_CR50","doi-asserted-by":"publisher","first-page":"3886","DOI":"10.1038\/s41598-023-31057-1","volume":"13","author":"TL Wiemken","year":"2023","unstructured":"Wiemken TL, Khan F, Puzniak L, et al. Seasonal trends in COVID-19 cases, hospitalizations, and mortality in the United States and Europe. Sci Rep. 2023;13(1):3886. https:\/\/doi.org\/10.1038\/s41598-023-31057-1.","journal-title":"Sci Rep"},{"issue":"6","key":"1080_CR51","doi-asserted-by":"publisher","DOI":"10.1128\/mbio.01426-23","volume":"14","author":"JP Townsend","year":"2023","unstructured":"Townsend JP, Hassler HB, Lamb AD, et al. Seasonality of endemic COVID-19. MBio. 2023;14(6): e0142623. https:\/\/doi.org\/10.1128\/mbio.01426-23.","journal-title":"MBio"},{"key":"1080_CR52","doi-asserted-by":"publisher","DOI":"10.12659\/msm.943911","volume":"30","author":"DV Parums","year":"2024","unstructured":"Parums DV. Editorial: global health concerns as vaccine-preventable infections including SARS-CoV-2 (JN.1), influenza, respiratory syncytial virus (RSV), and measles continue to rise. Med Sci Monit. 2024;30: e943911. https:\/\/doi.org\/10.12659\/msm.943911.","journal-title":"Med Sci Monit"},{"issue":"9","key":"1080_CR53","doi-asserted-by":"publisher","first-page":"862","DOI":"10.1016\/j.tim.2021.06.009","volume":"29","author":"MK Siggins","year":"2021","unstructured":"Siggins MK, Thwaites RS, Openshaw PJM. Durability of immunity to SARS-CoV-2 and other respiratory viruses: (Trends in Microbiology, 29, 648-662, 2021). Trends Microbiol. 2021;29(9):862. https:\/\/doi.org\/10.1016\/j.tim.2021.06.009.","journal-title":"Trends Microbiol"},{"key":"1080_CR54","doi-asserted-by":"publisher","first-page":"2347","DOI":"10.1016\/j.csbj.2021.04.043","volume":"19","author":"Z Abdelrahman","year":"2021","unstructured":"Abdelrahman Z, Chen Z, Lyu H, Wang X. Comparisons of the immunological landscape between COVID-19, influenza, and respiratory syncytial virus patients by clustering analysis. Comput Struct Biotechnol J. 2021;19:2347\u201355. https:\/\/doi.org\/10.1016\/j.csbj.2021.04.043.","journal-title":"Comput Struct Biotechnol J"},{"key":"1080_CR55","unstructured":"Centers for Disease Control and Prevention. Respiratory Syncytial Virus Infection (RSV) Symptoms and Care. https:\/\/www.cdc.gov\/rsv\/about\/symptoms.html. Accessed 20 Feb 2024."},{"key":"1080_CR56","unstructured":"Centers for Disease Control and Prevention. Influenza (Flu) Flu Symptoms & Complications. https:\/\/www.cdc.gov\/flu\/symptoms\/symptoms.htm. Accessed 20 Feb 2024."},{"key":"1080_CR57","unstructured":"Centers for Disease Control and Prevention. COVID-19 Symptoms of COVID-19. https:\/\/www.cdc.gov\/coronavirus\/2019-ncov\/symptoms-testing\/symptoms.html. Accessed 20 Feb 2024."},{"issue":"7","key":"1080_CR58","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pgph.0000221","volume":"2","author":"F Alemi","year":"2022","unstructured":"Alemi F, Vang J, Wojtusiak J, et al. Differential diagnosis of COVID-19 and influenza. PLOS Glob Public Health. 2022;2(7): e0000221. https:\/\/doi.org\/10.1371\/journal.pgph.0000221.","journal-title":"PLOS Glob Public Health"},{"issue":"3","key":"1080_CR59","doi-asserted-by":"publisher","DOI":"10.1016\/j.amjoto.2023.104176","volume":"45","author":"CI Cabrera","year":"2023","unstructured":"Cabrera CI, Hicks K, Rodriguez K, Gerka Stuyt JA, McComsey GA, D\u2019Anza B. Comparison of the incidence of smell and taste disorders between influenza and COVID-19. Am J Otolaryngol. 2023;45(3): 104176. https:\/\/doi.org\/10.1016\/j.amjoto.2023.104176.","journal-title":"Am J Otolaryngol"},{"key":"1080_CR60","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1136\/bmj.p3","volume":"380","author":"MK Looi","year":"2023","unstructured":"Looi MK. How are COVID-19 symptoms changing? BMJ. 2023;380:3. https:\/\/doi.org\/10.1136\/bmj.p3.","journal-title":"BMJ"},{"issue":"1","key":"1080_CR61","doi-asserted-by":"publisher","first-page":"374","DOI":"10.1186\/s12916-023-03070-8","volume":"21","author":"X Xu","year":"2023","unstructured":"Xu X, Wu Y, Kummer AG, et al. Assessing changes in incubation period, serial interval, and generation time of SARS-CoV-2 variants of concern: a systematic review and meta-analysis. BMC Med. 2023;21(1):374. https:\/\/doi.org\/10.1186\/s12916-023-03070-8.","journal-title":"BMC Med"},{"key":"1080_CR62","unstructured":"National Institutes of Health. Coronavirus Disease 2019 (COVID-19): Treatment Guidelines. https:\/\/www.covid19treatmentguidelines.nih.gov\/. Accessed 20 Feb 2024."},{"issue":"3","key":"1080_CR63","doi-asserted-by":"publisher","first-page":"371","DOI":"10.1128\/cmr.13.3.371","volume":"13","author":"AR Falsey","year":"2000","unstructured":"Falsey AR, Walsh EE. Respiratory syncytial virus infection in adults. Clin Microbiol Rev. 2000;13(3):371\u201384. https:\/\/doi.org\/10.1128\/cmr.13.3.371.","journal-title":"Clin Microbiol Rev"},{"key":"1080_CR64","unstructured":"Centers for Disease Control and Prevention. Influenza (Flu) Similarities and Differences between Flu and COVID-19. https:\/\/www.cdc.gov\/flu\/symptoms\/flu-vs-covid19.htm#anchor_1595599618. Accessed 20 Feb 2024."},{"key":"1080_CR65","unstructured":"Centers for Disease Control and Prevention. How flu spreads https:\/\/www.cdc.gov\/flu\/about\/disease\/spread.htm. Accessed 20 Feb 2024."},{"key":"1080_CR66","unstructured":"Centers for Disease Control and Prevention. How COVID-19 spreads https:\/\/www.cdc.gov\/coronavirus\/2019-ncov\/prevent-getting-sick\/how-covid-spreads.html. Accessed 20 Feb 2024."},{"key":"1080_CR67","unstructured":"Centers for Disease Control and Prevention. RSV Transmission. https:\/\/www.cdc.gov\/rsv\/causes\/. Accessed 20 Feb 2024."},{"issue":"8","key":"1080_CR68","doi-asserted-by":"publisher","first-page":"528","DOI":"10.1038\/s41579-021-00535-6","volume":"19","author":"NHL Leung","year":"2021","unstructured":"Leung NHL. Transmissibility and transmission of respiratory viruses. Nat Rev Microbiol. 2021;19(8):528\u201345. https:\/\/doi.org\/10.1038\/s41579-021-00535-6.","journal-title":"Nat Rev Microbiol"},{"key":"1080_CR69","doi-asserted-by":"publisher","DOI":"10.1126\/science.abd9149","author":"CC Wang","year":"2021","unstructured":"Wang CC, Prather KA, Sznitman J, et al. Airborne transmission of respiratory viruses. Science. 2021. https:\/\/doi.org\/10.1126\/science.abd9149.","journal-title":"Science"},{"issue":"1","key":"1080_CR70","doi-asserted-by":"publisher","DOI":"10.1101\/cshperspect.a038430","volume":"11","author":"J Nayak","year":"2021","unstructured":"Nayak J, Hoy G, Gordon A. Influenza in children. Cold Spring Harb Perspect Med. 2021;11(1): a038430. https:\/\/doi.org\/10.1101\/cshperspect.a038430.","journal-title":"Cold Spring Harb Perspect Med"},{"key":"1080_CR71","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1186\/1741-7015-7-30","volume":"7","author":"BJ Coburn","year":"2009","unstructured":"Coburn BJ, Wagner BG, Blower S. Modeling influenza epidemics and pandemics: insights into the future of swine flu (H1N1). BMC Med. 2009;7:30. https:\/\/doi.org\/10.1186\/1741-7015-7-30.","journal-title":"BMC Med"},{"issue":"10","key":"1080_CR72","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pcbi.1005133","volume":"12","author":"J Reis","year":"2016","unstructured":"Reis J, Shaman J. Retrospective parameter estimation and forecast of respiratory syncytial virus in the United States. PLoS Comput Biol. 2016;12(10): e1005133. https:\/\/doi.org\/10.1371\/journal.pcbi.1005133.","journal-title":"PLoS Comput Biol"},{"issue":"7","key":"1080_CR73","doi-asserted-by":"publisher","first-page":"1470","DOI":"10.3201\/eid2607.200282","volume":"26","author":"S Sanche","year":"2020","unstructured":"Sanche S, Lin YT, Xu C, Romero-Severson E, Hengartner N, Ke R. High contagiousness and rapid spread of severe acute respiratory syndrome coronavirus 2. Emerg Infect Dis. 2020;26(7):1470\u20137. https:\/\/doi.org\/10.3201\/eid2607.200282.","journal-title":"Emerg Infect Dis"},{"key":"1080_CR74","doi-asserted-by":"publisher","DOI":"10.1093\/jtm\/taac037","author":"Y Liu","year":"2022","unstructured":"Liu Y, Rockl\u00f6v J. The effective reproductive number of the Omicron variant of SARS-CoV-2 is several times relative to Delta. J Travel Med. 2022. https:\/\/doi.org\/10.1093\/jtm\/taac037.","journal-title":"J Travel Med"},{"key":"1080_CR75","unstructured":"World Health Organization. Global Influenza Surveillance and Response System (GISRS). https:\/\/www.who.int\/initiatives\/global-influenza-surveillance-and-response-system. Accessed 20 Feb 2024."},{"key":"1080_CR76","unstructured":"Netherlands Institute for Health Services Research (NIVEL). GERi: Global Epidemiology of RSV in primary and secondary care, monitoring https:\/\/www.nivel.nl\/en\/project\/geri-global-epidemiology-rsv-primary-and-secondary-care-monitoring-2019. Accessed 20 Feb 2024."},{"key":"1080_CR77","unstructured":"Centers for Disease Control and Prevention. RSV-NET Overview and Methods. https:\/\/www.cdc.gov\/rsv\/php\/surveillance\/rsv-net.html. Accessed 20 Feb 2024."},{"key":"1080_CR78","unstructured":"Centers for Disease Control and Prevention. Influenza (Flu) Influenza Hospitalization Surveillance Network (FluSurv-NET). https:\/\/www.cdc.gov\/flu\/weekly\/influenza-hospitalization-surveillance.htm. Accessed 20 Feb 2024."},{"key":"1080_CR79","unstructured":"Centers for Disease Control and Prevention. COVID-19 COVID-NET Overview and Methods. https:\/\/www.cdc.gov\/coronavirus\/2019-ncov\/covid-data\/covid-net\/purpose-methods.html#print. Accessed 20 Feb 2024."},{"key":"1080_CR80","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1186\/s12939-022-01767-5","volume":"21","author":"M Allan","year":"2022","unstructured":"Allan M, Li\u00e8vre M, Laurenson-Schafer H, et al. The World Health Organization COVID-19 surveillance database. Int J Equity Health. 2022;21:167. https:\/\/doi.org\/10.1186\/s12939-022-01767-5.","journal-title":"Int J Equity Health"},{"key":"1080_CR81","unstructured":"World Health Organization. WHO Health Emergencies Programme WHO COVID-19 dashboard. https:\/\/data.who.int\/dashboards\/covid19\/about?n=c. Accessed 20 Feb 2024."},{"key":"1080_CR82","unstructured":"Centers for Disease Control and Prevention. CDC Museum COVID-19 Timeline. https:\/\/www.cdc.gov\/museum\/timeline\/covid19.html. Accessed 20 Feb 2024."},{"key":"1080_CR83","unstructured":"World Health Organization. Global Influenza Programme. https:\/\/www.who.int\/teams\/global-influenza-programme\/surveillance-and-monitoring\/influenza-surveillance-outputs. Accessed 20 Feb 2024."},{"key":"1080_CR84","unstructured":"United Kingdom Health Security Agency. Notifiable diseases and causative organisms: how to report. https:\/\/www.gov.uk\/guidance\/notifiable-diseases-and-causative-organisms-how-to-report#list-of-notifiable-diseases. Accessed 20 Feb 2024."},{"key":"1080_CR85","unstructured":"Centers for Disease Control and Prevention. National Notifiable Diseases Surveillance System (NNDSS) Surveillance Case Definitions for Current and Historical Conditions. https:\/\/ndc.services.cdc.gov\/. Accessed 20 Feb 2024."},{"key":"1080_CR86","unstructured":"ECDC and WHO Regional Office for Europe. European Respiratory Virus Surveillance Summary. https:\/\/erviss.org\/. Accessed 20 Feb 2024."},{"issue":"1","key":"1080_CR87","doi-asserted-by":"publisher","first-page":"141","DOI":"10.3201\/eid3001.231011","volume":"30","author":"A Rector","year":"2024","unstructured":"Rector A, Bloemen M, Thijssen M, et al. Respiratory viruses in wastewater compared with clinical samples, Leuven, Belgium. Emerg Infect Dis. 2024;30(1):141\u20135. https:\/\/doi.org\/10.3201\/eid3001.231011.","journal-title":"Emerg Infect Dis"},{"key":"1080_CR88","doi-asserted-by":"publisher","DOI":"10.1016\/j.watres.2023.119648","volume":"231","author":"M Wolken","year":"2023","unstructured":"Wolken M, Sun T, McCall C, et al. Wastewater surveillance of SARS-CoV-2 and influenza in preK-12 schools shows school, community, and citywide infections. Water Res. 2023;231: 119648. https:\/\/doi.org\/10.1016\/j.watres.2023.119648.","journal-title":"Water Res"},{"key":"1080_CR89","unstructured":"National Foundation for Infectious Diseases. How to Tell the Difference between Flu, RSV, COVID-19, and the Common Cold. https:\/\/www.nfid.org\/resource\/how-to-tell-the-difference-between-flu-rsv-covid-19-and-the-common-cold\/. Accessed 20 Feb 2024."},{"issue":"4","key":"1080_CR90","doi-asserted-by":"publisher","DOI":"10.1016\/j.diagmicrobio.2023.115970","volume":"106","author":"C Houwen","year":"2023","unstructured":"Houwen C, van Lisdonk N, Bolier J, et al. Diagnostic performances of four commercially available assays for the identification of SARS-CoV-2, influenza type A\/B virus and RSV. Diagn Microbiol Infect Dis. 2023;106(4): 115970. https:\/\/doi.org\/10.1016\/j.diagmicrobio.2023.115970.","journal-title":"Diagn Microbiol Infect Dis"},{"key":"1080_CR91","unstructured":"Centers for Disease Control and Prevention. Influenza (Flu) Diagnosing Flu. https:\/\/www.cdc.gov\/flu\/symptoms\/testing.htm. Accessed 20 Feb 2024."},{"key":"1080_CR92","unstructured":"Centers for Disease Control and Prevention. Diagnostic Testing for RSV. https:\/\/www.cdc.gov\/rsv\/clinical\/index.html. Accessed 20 Feb 2024."},{"key":"1080_CR93","unstructured":"Centers for Disease Control and Prevention. COVID-19 Testing: What You Need to Know. https:\/\/www.cdc.gov\/covid\/testing\/. Accessed 20 Feb 2024."},{"issue":"1","key":"1080_CR94","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1016\/j.cmi.2022.07.010","volume":"29","author":"JE Kirby","year":"2023","unstructured":"Kirby JE, Riedel S, Dutta S, et al. SARS-CoV-2 antigen tests predict infectivity based on viral culture: comparison of antigen, PCR viral load, and viral culture testing on a large sample cohort. Clin Microbiol Infect. 2023;29(1):94\u2013100. https:\/\/doi.org\/10.1016\/j.cmi.2022.07.010.","journal-title":"Clin Microbiol Infect"},{"issue":"11","key":"1080_CR95","doi-asserted-by":"publisher","DOI":"10.1128\/jcm.00469-21","volume":"59","author":"MJ Binnicker","year":"2021","unstructured":"Binnicker MJ. Can testing predict SARS-CoV-2 infectivity? The potential for certain methods to be surrogates for replication-competent virus. J Clin Microbiol. 2021;59(11): e0046921. https:\/\/doi.org\/10.1128\/jcm.00469-21.","journal-title":"J Clin Microbiol"},{"key":"1080_CR96","unstructured":"Centers for Disease Control and Prevention. Information for Clinicians on Influenza Virus Testing. https:\/\/www.cdc.gov\/flu\/professionals\/diagnosis\/index.htm. Accessed 20 Feb 2024."},{"key":"1080_CR97","doi-asserted-by":"publisher","DOI":"10.1016\/j.jcv.2023.105399","volume":"161","author":"A Ambrosch","year":"2023","unstructured":"Ambrosch A, Luber D, Klawonn F, Kabesch M. Focusing on severe infections with the respiratory syncytial virus (RSV) in adults: risk factors, symptomatology and clinical course compared to influenza A \/ B and the original SARS-CoV-2 strain. J Clin Virol. 2023;161: 105399. https:\/\/doi.org\/10.1016\/j.jcv.2023.105399.","journal-title":"J Clin Virol"},{"issue":"17","key":"1080_CR98","doi-asserted-by":"publisher","first-page":"1749","DOI":"10.1056\/NEJMoa043951","volume":"352","author":"AR Falsey","year":"2005","unstructured":"Falsey AR, Hennessey PA, Formica MA, Cox C, Walsh EE. Respiratory syncytial virus infection in elderly and high-risk adults. N Engl J Med. 2005;352(17):1749\u201359. https:\/\/doi.org\/10.1056\/NEJMoa043951.","journal-title":"N Engl J Med"},{"issue":"11","key":"1080_CR99","doi-asserted-by":"publisher","first-page":"1706","DOI":"10.1093\/infdis\/jix196","volume":"215","author":"S Datta","year":"2017","unstructured":"Datta S, Walsh EE, Peterson DR, Falsey AR. Can analysis of routine viral testing provide accurate estimates of respiratory syncytial virus disease burden in adults? J Infect Dis. 2017;215(11):1706\u201310. https:\/\/doi.org\/10.1093\/infdis\/jix196.","journal-title":"J Infect Dis"},{"issue":"6","key":"1080_CR100","doi-asserted-by":"publisher","first-page":"969","DOI":"10.1093\/infdis\/jiz236","volume":"220","author":"N Lee","year":"2019","unstructured":"Lee N, Walsh EE, Sander I, et al. Delayed diagnosis of respiratory syncytial virus infections in hospitalized adults: individual patient data, record review analysis and physician survey in the United States. J Infect Dis. 2019;220(6):969\u201379. https:\/\/doi.org\/10.1093\/infdis\/jiz236.","journal-title":"J Infect Dis"},{"key":"1080_CR101","unstructured":"Cleveland Clinic. COVID-19-Related Testing Costs. https:\/\/my.clevelandclinic.org\/patients\/billing-finance\/comprehensive-hospital-charges\/covid-19-testing-costs. Accessed 20 Feb 2024."},{"key":"1080_CR102","doi-asserted-by":"publisher","DOI":"10.1001\/jamainternmed.2024.0037","author":"T Schober","year":"2024","unstructured":"Schober T, Wong K, DeLisle G, et al. Clinical outcomes of rapid respiratory virus testing in emergency departments: a systematic review and meta-analysis. JAMA Intern Med. 2024. https:\/\/doi.org\/10.1001\/jamainternmed.2024.0037.","journal-title":"JAMA Intern Med"},{"key":"1080_CR103","doi-asserted-by":"publisher","DOI":"10.1128\/jcm.02955-20","author":"HH Mostafa","year":"2021","unstructured":"Mostafa HH, Carroll KC, Hicken R, et al. Multicenter evaluation of the Cepheid Xpert Xpress SARS-CoV-2\/Flu\/RSV Test. J Clin Microbiol. 2021. https:\/\/doi.org\/10.1128\/jcm.02955-20.","journal-title":"J Clin Microbiol"},{"key":"1080_CR104","doi-asserted-by":"publisher","DOI":"10.1101\/2024.02.06.24302387","author":"BA Petros","year":"2024","unstructured":"Petros BA, Milliren CE, Sabeti PC, Ozonoff A. Increased pediatric RSV case counts following the emergence of SARS-CoV-2 are attributable to increased testing. medRxiv. 2024. https:\/\/doi.org\/10.1101\/2024.02.06.24302387.","journal-title":"medRxiv."},{"issue":"1","key":"1080_CR105","doi-asserted-by":"publisher","first-page":"3374","DOI":"10.1038\/s41467-024-47757-9","volume":"15","author":"E Rios-Guzman","year":"2024","unstructured":"Rios-Guzman E, Simons LM, Dean TJ, et al. Deviations in RSV epidemiological patterns and population structures in the United States following the COVID-19 pandemic. Nat Commun. 2024;15(1):3374. https:\/\/doi.org\/10.1038\/s41467-024-47757-9.","journal-title":"Nat Commun"},{"key":"1080_CR106","doi-asserted-by":"publisher","DOI":"10.1016\/j.jfma.2023.12.004","author":"WC Chang","year":"2023","unstructured":"Chang WC, Huang RC, Perng CL, Shang HS, Yu CM, Wang CH. Epidemiology and clinical characteristics of hospitalized adults with respiratory syncytial virus infection at a medical center in northern Taiwan. J Formos Med Assoc. 2023. https:\/\/doi.org\/10.1016\/j.jfma.2023.12.004.","journal-title":"J Formos Med Assoc"},{"issue":"12","key":"1080_CR107","doi-asserted-by":"publisher","first-page":"3738","DOI":"10.1128\/jcm.01816-15","volume":"53","author":"C Chartrand","year":"2015","unstructured":"Chartrand C, Tremblay N, Renaud C, Papenburg J. Diagnostic accuracy of rapid antigen detection tests for respiratory syncytial virus infection: systematic review and meta-analysis. J Clin Microbiol. 2015;53(12):3738\u201349. https:\/\/doi.org\/10.1128\/jcm.01816-15.","journal-title":"J Clin Microbiol"},{"issue":"2","key":"1080_CR108","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1093\/infdis\/jiad012","volume":"228","author":"C Onwuchekwa","year":"2023","unstructured":"Onwuchekwa C, Moreo LM, Menon S, et al. Underascertainment of respiratory syncytial virus infection in adults due to diagnostic testing limitations: a systematic literature review and meta-analysis. J Infect Dis. 2023;228(2):173\u201384. https:\/\/doi.org\/10.1093\/infdis\/jiad012.","journal-title":"J Infect Dis"},{"issue":"8","key":"1080_CR109","doi-asserted-by":"publisher","first-page":"1349","DOI":"10.3390\/mi13081349","volume":"13","author":"R Maia","year":"2022","unstructured":"Maia R, Carvalho V, Faria B, et al. Diagnosis methods for COVID-19: a systematic review. Micromachines (Basel). 2022;13(8):1349. https:\/\/doi.org\/10.3390\/mi13081349.","journal-title":"Micromachines (Basel)"},{"key":"1080_CR110","unstructured":"Centers for Disease Control and Prevention. Overview of testing for SARS-CoV-2, the virus that causes COVID-19. https:\/\/www.cdc.gov\/covid\/hcp\/testing\/. Accessed 20 Feb 2024."},{"key":"1080_CR111","unstructured":"US Food and Drug Administration. FDA Authorizes First Over-the-Counter At-Home Test to Detect Both Influenza and COVID-19 Viruses. https:\/\/www.fda.gov\/news-events\/press-announcements\/fda-authorizes-first-over-counter-home-test-detect-both-influenza-and-covid-19-viruses. Accessed 20 Feb 2024."},{"issue":"10","key":"1080_CR112","doi-asserted-by":"publisher","first-page":"e837","DOI":"10.1016\/s2666-5247(23)00135-0","volume":"4","author":"CS Laxton","year":"2023","unstructured":"Laxton CS, Peno C, Hahn AM, Allicock OM, Perniciaro S, Wyllie AL. The potential of saliva as an accessible and sensitive sample type for the detection of respiratory pathogens and host immunity. Lancet Microbe. 2023;4(10):e837\u201350. https:\/\/doi.org\/10.1016\/s2666-5247(23)00135-0.","journal-title":"Lancet Microbe"},{"issue":"5","key":"1080_CR113","doi-asserted-by":"publisher","first-page":"1160","DOI":"10.3390\/v15051160","volume":"15","author":"N Principi","year":"2023","unstructured":"Principi N, Autore G, Ramundo G, Esposito S. Epidemiology of respiratory infections during the COVID-19 pandemic. Viruses. 2023;15(5):1160. https:\/\/doi.org\/10.3390\/v15051160.","journal-title":"Viruses"},{"key":"1080_CR114","doi-asserted-by":"publisher","first-page":"1002","DOI":"10.1016\/j.ijid.2022.08.002","volume":"122","author":"SS Lee","year":"2022","unstructured":"Lee SS, Viboud C, Petersen E. Understanding the rebound of influenza in the post COVID-19 pandemic period holds important clues for epidemiology and control. Int J Infect Dis. 2022;122:1002\u20134. https:\/\/doi.org\/10.1016\/j.ijid.2022.08.002.","journal-title":"Int J Infect Dis"},{"key":"1080_CR115","unstructured":"Centers for Disease Control and Prevention. CDC Tracks Ongoing Flu Activity in the Southern Hemisphere. https:\/\/www.cdc.gov\/flu\/spotlights\/2022-2023\/ongoing-flu-southern-hemisphere.htm. Accessed 20 Feb 2024."},{"issue":"12","key":"1080_CR116","doi-asserted-by":"publisher","first-page":"2556","DOI":"10.3201\/eid2912.230937","volume":"29","author":"W Xiong","year":"2023","unstructured":"Xiong W, Cowling BJ, Tsang TK. Influenza resurgence after relaxation of public health and social measures, Hong Kong, 2023. Emerg Infect Dis. 2023;29(12):2556\u20139. https:\/\/doi.org\/10.3201\/eid2912.230937.","journal-title":"Emerg Infect Dis"},{"key":"1080_CR117","doi-asserted-by":"crossref","unstructured":"Caini S, Meijer A, Nunes M, et al. Is influenza B\/Yamagata extinct and what public health implications could this have? An updated literature review and comprehensive assessment of global surveillance databases. medRxiv. 2023.","DOI":"10.1101\/2023.09.25.23296068"},{"key":"1080_CR118","doi-asserted-by":"publisher","unstructured":"Hamid S, Winn A, Parikh R, et al. Seasonality of Respiratory Syncytial Virus\u2014United States, 2017\u20132023. MMWR Morb Mortal Wkly Rep. 2023;72(14):355\u201361. https:\/\/doi.org\/10.15585\/mmwr.mm7214a1.","DOI":"10.15585\/mmwr.mm7214a1"},{"issue":"3","key":"1080_CR119","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1038\/s41579-022-00807-9","volume":"21","author":"EJ Chow","year":"2023","unstructured":"Chow EJ, Uyeki TM, Chu HY. The effects of the COVID-19 pandemic on community respiratory virus activity. Nat Rev Microbiol. 2023;21(3):195\u2013210. https:\/\/doi.org\/10.1038\/s41579-022-00807-9.","journal-title":"Nat Rev Microbiol"},{"issue":"1","key":"1080_CR120","doi-asserted-by":"publisher","first-page":"2884","DOI":"10.1038\/s41467-022-30485-3","volume":"13","author":"JS Eden","year":"2022","unstructured":"Eden JS, Sikazwe C, Xie R, et al. Off-season RSV epidemics in Australia after easing of COVID-19 restrictions. Nat Commun. 2022;13(1):2884. https:\/\/doi.org\/10.1038\/s41467-022-30485-3.","journal-title":"Nat Commun"},{"issue":"14","key":"1080_CR121","doi-asserted-by":"publisher","first-page":"1335","DOI":"10.1056\/NEJMc2216153","volume":"388","author":"G Adams","year":"2023","unstructured":"Adams G, Moreno GK, Petros BA, et al. Viral lineages in the 2022 RSV surge in the United States. N Engl J Med. 2023;388(14):1335\u20137. https:\/\/doi.org\/10.1056\/NEJMc2216153.","journal-title":"N Engl J Med"},{"issue":"1","key":"1080_CR122","doi-asserted-by":"publisher","first-page":"16","DOI":"10.3390\/diseases12010016","volume":"12","author":"H Kopel","year":"2024","unstructured":"Kopel H, Bogdanov A, Winer-Jones JP, et al. Comparison of COVID-19 and influenza-related outcomes in the United States during fall-winter 2022\u20132023: a cross-sectional retrospective study. Diseases. 2024;12(1):16. https:\/\/doi.org\/10.3390\/diseases12010016.","journal-title":"Diseases"},{"key":"1080_CR123","doi-asserted-by":"publisher","unstructured":"Surie D, Yuengling KA, DeCuir J, et al. Disease severity of respiratory syncytial virus compared with COVID-19 and influenza among hospitalized adults aged \u226560 years\u2014IVY Network, 20 U.S. States, February 2022-May 2023. MMWR Morb Mortal Wkly Rep. 2023;72(40):1083\u20138. https:\/\/doi.org\/10.15585\/mmwr.mm7240a2.","DOI":"10.15585\/mmwr.mm7240a2"},{"key":"1080_CR124","doi-asserted-by":"crossref","unstructured":"Nacov JA, Salmanton-Garcia J, Heringer S, et al. Epidemiology of acute respiratory infection with SARS-CoV-2, influenza A & B viruses, respiratory syncytial virus, and adenovirus in VACCELERATE volunteers in Germany. SSRN; 2023.","DOI":"10.2139\/ssrn.4612721"},{"issue":"4","key":"1080_CR125","doi-asserted-by":"publisher","first-page":"900","DOI":"10.1093\/cid\/ciad660","volume":"78","author":"P Hedberg","year":"2023","unstructured":"Hedberg P, Karlsson Valik J, Abdel Halim L, Alfv\u00e9n T, Naucler P. Outcomes of SARS-CoV-2 omicron variant infections compared with seasonal influenza and respiratory syncytial virus infections in adults attending the emergency department: a multicentre cohort study. Clin Infect Dis. 2023;78(4):900\u20137. https:\/\/doi.org\/10.1093\/cid\/ciad660.","journal-title":"Clin Infect Dis"},{"key":"1080_CR126","unstructured":"Centers for Disease Control and Prevention. Background for CDC\u2019s Updated Respiratory Virus Guidance. https:\/\/www.cdc.gov\/respiratory-viruses\/background\/index.html#print. Accessed 20 Feb 2024."},{"issue":"7980","key":"1080_CR127","doi-asserted-by":"publisher","first-page":"S60","DOI":"10.1038\/d41586-023-02959-x","volume":"621","author":"K Bourzac","year":"2023","unstructured":"Bourzac K. Respiratory syncytial virus co-infections might conspire to worsen disease. Nature. 2023;621(7980):S60\u20131. https:\/\/doi.org\/10.1038\/d41586-023-02959-x.","journal-title":"Nature"},{"key":"1080_CR128","doi-asserted-by":"publisher","first-page":"1308105","DOI":"10.3389\/fped.2023.1308105","volume":"11","author":"L Matera","year":"2023","unstructured":"Matera L, Manti S, Petrarca L, et al. An overview on viral interference during SARS-CoV-2 pandemic. Front Pediatr. 2023;11:1308105. https:\/\/doi.org\/10.3389\/fped.2023.1308105.","journal-title":"Front Pediatr"},{"issue":"10334","key":"1080_CR129","doi-asserted-by":"publisher","first-page":"1463","DOI":"10.1016\/s0140-6736(22)00383-x","volume":"399","author":"MC Swets","year":"2022","unstructured":"Swets MC, Russell CD, Harrison EM, et al. SARS-CoV-2 co-infection with influenza viruses, respiratory syncytial virus, or adenoviruses. Lancet. 2022;399(10334):1463\u20134. https:\/\/doi.org\/10.1016\/s0140-6736(22)00383-x.","journal-title":"Lancet"},{"key":"1080_CR130","doi-asserted-by":"publisher","DOI":"10.3389\/fpubh.2022.959319","volume":"10","author":"I Trifonova","year":"2022","unstructured":"Trifonova I, Christova I, Madzharova I, et al. Clinical significance and role of coinfections with respiratory pathogens among individuals with confirmed severe acute respiratory syndrome coronavirus-2 infection. Front Public Health. 2022;10: 959319. https:\/\/doi.org\/10.3389\/fpubh.2022.959319.","journal-title":"Front Public Health"},{"issue":"11","key":"1080_CR131","doi-asserted-by":"publisher","first-page":"1879","DOI":"10.1038\/s41564-022-01242-5","volume":"7","author":"J Haney","year":"2022","unstructured":"Haney J, Vijayakrishnan S, Streetley J, et al. Coinfection by influenza A virus and respiratory syncytial virus produces hybrid virus particles. Nat Microbiol. 2022;7(11):1879\u201390. https:\/\/doi.org\/10.1038\/s41564-022-01242-5.","journal-title":"Nat Microbiol"},{"issue":"4","key":"1080_CR132","doi-asserted-by":"publisher","first-page":"345","DOI":"10.1056\/NEJMoa1702090","volume":"378","author":"JC Kwong","year":"2018","unstructured":"Kwong JC, Schwartz KL, Campitelli MA, et al. Acute myocardial infarction after laboratory-confirmed influenza infection. N Engl J Med. 2018;378(4):345\u201353. https:\/\/doi.org\/10.1056\/NEJMoa1702090.","journal-title":"N Engl J Med"},{"issue":"14","key":"1080_CR133","doi-asserted-by":"publisher","first-page":"1574","DOI":"10.1016\/j.jacc.2018.02.013","volume":"71","author":"KS Ivey","year":"2018","unstructured":"Ivey KS, Edwards KM, Talbot HK. Respiratory syncytial virus and associations with cardiovascular disease in adults. J Am Coll Cardiol. 2018;71(14):1574\u201383. https:\/\/doi.org\/10.1016\/j.jacc.2018.02.013.","journal-title":"J Am Coll Cardiol"},{"key":"1080_CR134","doi-asserted-by":"publisher","DOI":"10.1001\/jamainternmed.2024.0212","author":"RC Woodruff","year":"2024","unstructured":"Woodruff RC, Melgar M, Pham H, et al. Acute cardiac events in hospitalized older adults with respiratory syncytial virus infection. JAMA Intern Med. 2024. https:\/\/doi.org\/10.1001\/jamainternmed.2024.0212.","journal-title":"JAMA Intern Med"},{"issue":"3","key":"1080_CR135","doi-asserted-by":"publisher","first-page":"583","DOI":"10.1038\/s41591-022-01689-3","volume":"28","author":"Y Xie","year":"2022","unstructured":"Xie Y, Xu E, Bowe B, Al-Aly Z. Long-term cardiovascular outcomes of COVID-19. Nat Med. 2022;28(3):583\u201390. https:\/\/doi.org\/10.1038\/s41591-022-01689-3.","journal-title":"Nat Med"},{"key":"1080_CR136","doi-asserted-by":"publisher","DOI":"10.1183\/16000617.0063-2018","author":"D Linden","year":"2019","unstructured":"Linden D, Guo-Parke H, Coyle PV, et al. Respiratory viral infection: a potential \u201cmissing link\u201d in the pathogenesis of COPD. Eur Respir Rev. 2019. https:\/\/doi.org\/10.1183\/16000617.0063-2018.","journal-title":"Eur Respir Rev"},{"issue":"suppl 1","key":"1080_CR137","doi-asserted-by":"publisher","first-page":"S70","DOI":"10.1093\/infdis\/jiad510","volume":"229","author":"R Osei-Yeboah","year":"2024","unstructured":"Osei-Yeboah R, Johannesen CK, Egeskov-Cavling AM, et al. Respiratory syncytial virus-associated hospitalization in adults with comorbidities in 2 European countries: a modeling study. J Infect Dis. 2024;229(suppl 1):S70\u20137. https:\/\/doi.org\/10.1093\/infdis\/jiad510.","journal-title":"J Infect Dis"},{"issue":"11","key":"1080_CR138","doi-asserted-by":"publisher","first-page":"3791","DOI":"10.3390\/jcm12113791","volume":"12","author":"NT Awatade","year":"2023","unstructured":"Awatade NT, Wark PAB, Chan ASL, et al. The complex association between COPD and COVID-19. J Clin Med. 2023;12(11):3791. https:\/\/doi.org\/10.3390\/jcm12113791.","journal-title":"J Clin Med"},{"key":"1080_CR139","doi-asserted-by":"publisher","DOI":"10.3389\/fmed.2022.882665","volume":"9","author":"RC Agondi","year":"2022","unstructured":"Agondi RC, Menechino N, Marinho A, Kalil J, Giavina-Bianchi P. Worsening of asthma control after COVID-19. Front Med (Lausanne). 2022;9: 882665. https:\/\/doi.org\/10.3389\/fmed.2022.882665.","journal-title":"Front Med (Lausanne)"},{"issue":"3","key":"1080_CR140","doi-asserted-by":"publisher","first-page":"2146","DOI":"10.3390\/ijerph20032146","volume":"20","author":"E Rudnicka-Dro\u017cak","year":"2023","unstructured":"Rudnicka-Dro\u017cak E, Dro\u017cak P, Mizerski G, et al. Links between COVID-19 and Alzheimer\u2019s disease-what do we already know? Int J Environ Res Public Health. 2023;20(3):2146. https:\/\/doi.org\/10.3390\/ijerph20032146.","journal-title":"Int J Environ Res Public Health"},{"key":"1080_CR141","doi-asserted-by":"publisher","DOI":"10.1093\/infdis\/jiad596","author":"KJ Pollard","year":"2023","unstructured":"Pollard KJ, Traina-Dorge V, Medearis SM, et al. Respiratory syncytial virus infects peripheral and spinal nerves and induces chemokine-mediated neuropathy. J Infect Dis. 2023. https:\/\/doi.org\/10.1093\/infdis\/jiad596.","journal-title":"J Infect Dis"},{"issue":"7","key":"1080_CR142","doi-asserted-by":"publisher","first-page":"1086","DOI":"10.1016\/j.neuron.2022.12.029","volume":"111","author":"KS Levine","year":"2023","unstructured":"Levine KS, Leonard HL, Blauwendraat C, et al. Virus exposure and neurodegenerative disease risk across national biobanks. Neuron. 2023;111(7):1086-93.e2. https:\/\/doi.org\/10.1016\/j.neuron.2022.12.029.","journal-title":"Neuron"},{"issue":"3","key":"1080_CR143","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1038\/s41579-022-00846-2","volume":"21","author":"HE Davis","year":"2023","unstructured":"Davis HE, McCorkell L, Vogel JM, Topol EJ. Long COVID: major findings, mechanisms and recommendations. Nat Rev Microbiol. 2023;21(3):133\u201346. https:\/\/doi.org\/10.1038\/s41579-022-00846-2.","journal-title":"Nat Rev Microbiol"},{"key":"1080_CR144","unstructured":"National Institute on Aging. What Do We Know About Long COVID? https:\/\/www.nia.nih.gov\/health\/covid-19\/what-do-we-know-about-long-covid. Accessed 20 Feb 2024."},{"issue":"1","key":"1080_CR145","doi-asserted-by":"publisher","first-page":"5663","DOI":"10.1038\/s41467-022-33415-5","volume":"13","author":"CE Hastie","year":"2022","unstructured":"Hastie CE, Lowe DJ, McAuley A, et al. Outcomes among confirmed cases and a matched comparison group in the Long-COVID in Scotland study. Nat Commun. 2022;13(1):5663. https:\/\/doi.org\/10.1038\/s41467-022-33415-5.","journal-title":"Nat Commun"},{"issue":"1","key":"1080_CR146","doi-asserted-by":"publisher","first-page":"6588","DOI":"10.1038\/s41467-023-41879-2","volume":"14","author":"CJ Atchison","year":"2023","unstructured":"Atchison CJ, Davies B, Cooper E, et al. Long-term health impacts of COVID-19 among 242,712 adults in England. Nat Commun. 2023;14(1):6588. https:\/\/doi.org\/10.1038\/s41467-023-41879-2.","journal-title":"Nat Commun"},{"key":"1080_CR147","doi-asserted-by":"publisher","unstructured":"Ford ND, Slaughter D, Edwards D, et al. Long COVID and significant activity limitation among adults, by age\u2014United States, June 1\u201313, 2022, to June 7\u201319, 2023. MMWR Morb Mortal Wkly Rep. 2023;72(32):866\u201370. https:\/\/doi.org\/10.15585\/mmwr.mm7232a3.","DOI":"10.15585\/mmwr.mm7232a3"},{"issue":"5","key":"1080_CR148","doi-asserted-by":"publisher","first-page":"911","DOI":"10.1038\/s41591-022-01810-6","volume":"28","author":"J Choutka","year":"2022","unstructured":"Choutka J, Jansari V, Hornig M, Iwasaki A. Unexplained post-acute infection syndromes. Nat Med. 2022;28(5):911\u201323. https:\/\/doi.org\/10.1038\/s41591-022-01810-6.","journal-title":"Nat Med"},{"issue":"6","key":"1080_CR149","doi-asserted-by":"publisher","first-page":"1151","DOI":"10.1111\/irv.13043","volume":"16","author":"AR Branche","year":"2022","unstructured":"Branche AR, Saiman L, Walsh EE, et al. Change in functional status associated with respiratory syncytial virus infection in hospitalized older adults. Influenza Other Respir Viruses. 2022;16(6):1151\u201360. https:\/\/doi.org\/10.1111\/irv.13043.","journal-title":"Influenza Other Respir Viruses"},{"issue":"3","key":"1080_CR150","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1002\/agm2.12258","volume":"6","author":"M K\u00f6nig","year":"2023","unstructured":"K\u00f6nig M, Gollasch M, Komleva Y. Frailty after COVID-19: the wave after? Aging Med (Milton). 2023;6(3):307\u201316. https:\/\/doi.org\/10.1002\/agm2.12258.","journal-title":"Aging Med (Milton)"},{"issue":"1147","key":"1080_CR151","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1136\/postgradmedj-2020-139070","volume":"97","author":"ST Liang","year":"2021","unstructured":"Liang ST, Liang LT, Rosen JM. COVID-19: a comparison to the 1918 influenza and how we can defeat it. Postgrad Med J. 2021;97(1147):273\u20134. https:\/\/doi.org\/10.1136\/postgradmedj-2020-139070.","journal-title":"Postgrad Med J"},{"issue":"3","key":"1080_CR152","doi-asserted-by":"publisher","first-page":"565","DOI":"10.1111\/j.1728-4457.2000.00565.x","volume":"26","author":"A Noymer","year":"2000","unstructured":"Noymer A, Garenne M. The 1918 influenza epidemic\u2019s effects on sex differentials in mortality in the United States. Popul Dev Rev. 2000;26(3):565\u201381. https:\/\/doi.org\/10.1111\/j.1728-4457.2000.00565.x.","journal-title":"Popul Dev Rev"},{"key":"1080_CR153","doi-asserted-by":"publisher","unstructured":"Ahmad FB, Cisewski JA, Anderson RN. Provisional Mortality Data\u2014United States, 2021. MMWR Morb Mortal Wkly Rep. 2022;71(17):597\u2013600. https:\/\/doi.org\/10.15585\/mmwr.mm7117e1.","DOI":"10.15585\/mmwr.mm7117e1"},{"issue":"1","key":"1080_CR154","doi-asserted-by":"publisher","first-page":"3065","DOI":"10.1038\/s41598-023-30077-1","volume":"13","author":"S Silva","year":"2023","unstructured":"Silva S, Goosby E, Reid MJA. Assessing the impact of one million COVID-19 deaths in America: economic and life expectancy losses. Sci Rep. 2023;13(1):3065. https:\/\/doi.org\/10.1038\/s41598-023-30077-1.","journal-title":"Sci Rep"},{"issue":"10440","key":"1080_CR155","doi-asserted-by":"publisher","first-page":"1989","DOI":"10.1016\/S0140-6736(24)00476-8","volume":"403","author":"AE Schumacher","year":"2024","unstructured":"Schumacher AE, Kyu HH, Aali A, et al. Global age-sex-specific mortality, life expectancy, and population estimates in 204 countries and territories and 811 subnational locations, 1950\u20132021, and the impact of the COVID-19 pandemic: a comprehensive demographic analysis for the Global Burden of Disease Study 2021. Lancet. 2024;403(10440):1989\u20132056. https:\/\/doi.org\/10.1016\/S0140-6736(24)00476-8.","journal-title":"Lancet"},{"issue":"3","key":"1080_CR156","doi-asserted-by":"publisher","first-page":"945","DOI":"10.1007\/s12325-023-02770-0","volume":"41","author":"J Langer","year":"2024","unstructured":"Langer J, Welch VL, Moran MM, et al. The cost of seasonal influenza: a systematic literature review on the humanistic and economic burden of influenza in older (\u2265 65 years old) adults. Adv Ther. 2024;41(3):945\u201366. https:\/\/doi.org\/10.1007\/s12325-023-02770-0.","journal-title":"Adv Ther"},{"issue":"27","key":"1080_CR157","doi-asserted-by":"publisher","first-page":"3960","DOI":"10.1016\/j.vaccine.2018.05.057","volume":"36","author":"W Putri","year":"2018","unstructured":"Putri W, Muscatello DJ, Stockwell MS, Newall AT. Economic burden of seasonal influenza in the United States. Vaccine. 2018;36(27):3960\u20136. https:\/\/doi.org\/10.1016\/j.vaccine.2018.05.057.","journal-title":"Vaccine"},{"issue":"1","key":"1080_CR158","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0169344","volume":"12","author":"Y Young-Xu","year":"2017","unstructured":"Young-Xu Y, van Aalst R, Russo E, Lee JK, Chit A. The annual burden of seasonal influenza in the US Veterans Affairs population. PLoS\u00a0One. 2017;12(1): e0169344. https:\/\/doi.org\/10.1371\/journal.pone.0169344.","journal-title":"PLoS\u00a0One"},{"issue":"1","key":"1080_CR159","doi-asserted-by":"publisher","first-page":"742","DOI":"10.1080\/13696998.2023.2213125","volume":"26","author":"M Grace","year":"2023","unstructured":"Grace M, Colosia A, Wolowacz S, Panozzo C, Ghaswalla P. Economic burden of respiratory syncytial virus infection in adults: a systematic literature review. J Med Econ. 2023;26(1):742\u201359. https:\/\/doi.org\/10.1080\/13696998.2023.2213125.","journal-title":"J Med Econ"},{"issue":"6","key":"1080_CR160","doi-asserted-by":"publisher","first-page":"962","DOI":"10.1093\/infdis\/jiaa183","volume":"222","author":"B Ackerson","year":"2020","unstructured":"Ackerson B, An J, Sy LS, Solano Z, Slezak J, Tseng HF. Cost of hospitalization associated with respiratory syncytial virus infection versus influenza infection in hospitalized older adults. J Infect Dis. 2020;222(6):962\u20136. https:\/\/doi.org\/10.1093\/infdis\/jiaa183.","journal-title":"J Infect Dis"},{"key":"1080_CR161","doi-asserted-by":"publisher","unstructured":"Carrico J, Hicks KA, Wilson E, Panozzo CA, Ghaswalla P. The annual economic burden of respiratory syncytial virus in adults in the United States. J Infect Dis. 2023:jiad559. https:\/\/doi.org\/10.1093\/infdis\/jiad559.","DOI":"10.1093\/infdis\/jiad559"},{"issue":"4","key":"1080_CR162","doi-asserted-by":"publisher","first-page":"788","DOI":"10.3390\/antibiotics12040788","volume":"12","author":"S Debes","year":"2023","unstructured":"Debes S, Haug JB, De Blasio BF, Lindstr\u00f8m JC, Jonassen CM, Dudman SG. Antibiotic consumption in a cohort of hospitalized adults with viral respiratory tract infection. Antibiotics (Basel). 2023;12(4):788. https:\/\/doi.org\/10.3390\/antibiotics12040788.","journal-title":"Antibiotics (Basel)"},{"issue":"1","key":"1080_CR163","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1111\/irv.12912","volume":"16","author":"Y Choi","year":"2022","unstructured":"Choi Y, Hill-Ricciuti A, Branche AR, et al. Cost determinants among adults hospitalized with respiratory syncytial virus in the United States, 2017\u20132019. Influenza Other Respir Viruses. 2022;16(1):151\u20138. https:\/\/doi.org\/10.1111\/irv.12912.","journal-title":"Influenza Other Respir Viruses"},{"issue":"10","key":"1080_CR164","doi-asserted-by":"publisher","DOI":"10.1136\/bmjopen-2023-077602","volume":"13","author":"C Vardavas","year":"2023","unstructured":"Vardavas C, Zisis K, Nikitara K, et al. Cost of the COVID-19 pandemic versus the cost-effectiveness of mitigation strategies in EU\/UK\/OECD: a systematic review. BMJ Open. 2023;13(10): e077602. https:\/\/doi.org\/10.1136\/bmjopen-2023-077602.","journal-title":"BMJ Open"},{"issue":"9","key":"1080_CR165","doi-asserted-by":"publisher","first-page":"936","DOI":"10.18553\/jmcp.2022.22050","volume":"28","author":"JK DeMartino","year":"2022","unstructured":"DeMartino JK, Swallow E, Goldschmidt D, et al. Direct health care costs associated with COVID-19 in the United States. J Manag Care Spec Pharm. 2022;28(9):936\u201347. https:\/\/doi.org\/10.18553\/jmcp.2022.22050.","journal-title":"J Manag Care Spec Pharm"},{"issue":"12","key":"1080_CR166","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2023.47318","volume":"6","author":"NL Hair","year":"2023","unstructured":"Hair NL, Urban C. Association of severe COVID-19 and persistent COVID-19 symptoms with economic hardship among US families. JAMA Netw Open. 2023;6(12): e2347318. https:\/\/doi.org\/10.1001\/jamanetworkopen.2023.47318.","journal-title":"JAMA Netw Open"},{"issue":"1","key":"1080_CR167","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1186\/s12875-023-02196-1","volume":"24","author":"J Tufts","year":"2023","unstructured":"Tufts J, Guan N, Zemedikun DT, et al. The cost of primary care consultations associated with long COVID in non-hospitalised adults: a retrospective cohort study using UK primary care data. BMC Prim Care. 2023;24(1):245. https:\/\/doi.org\/10.1186\/s12875-023-02196-1.","journal-title":"BMC Prim Care"},{"key":"1080_CR168","doi-asserted-by":"publisher","DOI":"10.1183\/16000617.0105-2022","author":"JS Nguyen-Van-Tam","year":"2022","unstructured":"Nguyen-Van-Tam JS, O\u2019Leary M, Martin ET, et al. Burden of respiratory syncytial virus infection in older and high-risk adults: a systematic review and meta-analysis of the evidence from developed countries. Eur Respir Rev. 2022. https:\/\/doi.org\/10.1183\/16000617.0105-2022.","journal-title":"Eur Respir Rev"},{"issue":"12","key":"1080_CR169","doi-asserted-by":"publisher","first-page":"ofy316","DOI":"10.1093\/ofid\/ofy316","volume":"5","author":"EA Belongia","year":"2018","unstructured":"Belongia EA, King JP, Kieke BA, et al. Clinical features, severity, and incidence of RSV illness during 12 consecutive seasons in a community cohort of adults \u226560 years old. Open Forum Infect Dis. 2018;5(12):ofy316. https:\/\/doi.org\/10.1093\/ofid\/ofy316.","journal-title":"Open Forum Infect Dis"},{"issue":"7","key":"1080_CR170","doi-asserted-by":"publisher","first-page":"1046","DOI":"10.1086\/511986","volume":"195","author":"EE Walsh","year":"2007","unstructured":"Walsh EE, Peterson DR, Falsey AR. Is clinical recognition of respiratory syncytial virus infection in hospitalized elderly and high-risk. J Infect Dis. 2007;195(7):1046\u201351. https:\/\/doi.org\/10.1086\/511986.","journal-title":"J Infect Dis"},{"key":"1080_CR171","unstructured":"Centers for Disease Control and Prevention. Influenza (Flu) U.S. Influenza Surveillance: Purpose and Methods. https:\/\/www.cdc.gov\/flu\/weekly\/overview.htm. Accessed 20 Feb 2024."},{"key":"1080_CR172","unstructured":"Centers for Disease Control and Prevention. The National Respiratory and Enteric Virus Surveillance System (NREVSS) https:\/\/www.cdc.gov\/nrevss\/php\/dashboard\/index.html. Accessed 20 Feb 2024."},{"key":"1080_CR173","unstructured":"Centers for Disease Control and Prevention. RSV Symptoms and Care. https:\/\/www.cdc.gov\/rsv\/about\/symptoms.html. Accessed 20 Feb 2024."},{"key":"1080_CR174","unstructured":"Centers for Disease Control and Prevention. Influenza (Flu) Clinical Signs and Symptoms of Influenza. https:\/\/www.cdc.gov\/flu\/professionals\/acip\/clinical.htm#:~:text=Uncomplicated%20influenza%20signs%20and%20symptoms,those%20with%20chronic%20lung%20disease. Accessed 20 Feb 2024."},{"issue":"12","key":"1080_CR175","doi-asserted-by":"publisher","first-page":"1200","DOI":"10.1001\/jama.2023.16932","volume":"330","author":"KA Linder","year":"2023","unstructured":"Linder KA, Malani PN. RSV infection in older adults. JAMA. 2023;330(12):1200. https:\/\/doi.org\/10.1001\/jama.2023.16932.","journal-title":"JAMA"},{"key":"1080_CR176","unstructured":"World Health Organization. Coronavirus Disease (COVID-19). https:\/\/www.who.int\/news-room\/fact-sheets\/detail\/coronavirus-disease-(covid-19). Accessed 20 Feb 2024."},{"issue":"6","key":"1080_CR177","doi-asserted-by":"publisher","first-page":"1687","DOI":"10.1128\/aem.02051-06","volume":"73","author":"SA Boone","year":"2007","unstructured":"Boone SA, Gerba CP. Significance of fomites in the spread of respiratory and enteric viral disease. Appl Environ Microbiol. 2007;73(6):1687\u201396. https:\/\/doi.org\/10.1128\/aem.02051-06.","journal-title":"Appl Environ Microbiol"},{"key":"1080_CR178","unstructured":"National Center for Immunization Respiratory Diseases Division of Viral Diseases. Science Brief: SARS-CoV-2 and Surface (Fomite) Transmission for Indoor Community Environments. CDC COVID-19 Science Briefs. Atlanta (GA): Centers for Disease Control and Prevention (US); 2020."}],"container-title":["Infectious Diseases and Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40121-024-01080-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s40121-024-01080-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40121-024-01080-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,1,11]],"date-time":"2025-01-11T07:09:42Z","timestamp":1736579382000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s40121-024-01080-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,12,30]]},"references-count":178,"journal-issue":{"issue":"S1","published-print":{"date-parts":[[2025,1]]}},"alternative-id":["1080"],"URL":"https:\/\/doi.org\/10.1007\/s40121-024-01080-4","relation":{},"ISSN":["2193-8229","2193-6382"],"issn-type":[{"value":"2193-8229","type":"print"},{"value":"2193-6382","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,12,30]]},"assertion":[{"value":"3 June 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 November 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 December 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"William P Hanage is a scientific advisor to Biobot Analytics and has consulted for Merck Vaccines, Pfizer, and Shinogi Inc. William Schaffner has nothing to disclose.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"This article is based on previously conducted studies and does not contain any new studies with human participants or animals performed by any of the authors.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}}]}}